Pharmacists for Fair Reimbursement What your state's PBM laws actually mean for community pharmacies
State Tracker Updated June 15, 2026

District of Columbia: what the PBM reimbursement law requires

The District regulates PBMs through a fiduciary duty, conflict-of-interest disclosure, and full pass-through of manufacturer rebates — but it has no reimbursement floor and no MAC pricing or appeal statute.

Status Partially enacted
Law AccessRx Act — D.C. Code §§ 48-832.01 to 48-832.02
Effective date 2004
Reimbursement basis No reimbursement floor and no MAC pricing/appeal statute. A PBM owes a fiduciary duty to the covered entity, must disclose conflicts of interest, and must pass through manufacturer payments and rebates in full. District Medicaid sets its own pharmacy reimbursement separately.
Professional dispensing fee Not specified in statute

The District of Columbia regulates PBM conduct rather than pharmacy reimbursement. Its PBM statute (the AccessRx Act, D.C. Code §§ 48-832.01–.02) imposes a fiduciary duty on the PBM toward the covered entity, requires conflict-of-interest disclosure, and requires full pass-through of manufacturer payments and rebates.

There is no MAC pricing or appeal requirement and no reimbursement floor in the commercial PBM statute; District Medicaid sets its own pharmacy reimbursement under separate rules. The District is therefore shown here as regulating PBMs without a floor.

Sources

Back to the tracker